Sangamo BioSciences has appointed Philip Gregory to vice-president of research, the company said today. The appointment is effective as of Oct. 26.
Sangamo's senior director of research since July 2003, Gregory has been at the company since 2000. Prior to Sangamo, Gregory was at the University of Munich, Germany. He received his D. Phil. in biochemistry from the University of Oxford, United Kingdom, and holds a Bachelor of Science. in Microbiology from the University of Sheffield, United Kingdom.
HistoRx announced the appointment of Ronald M. Lindsay, the former chief scientific officer and vice president of research and development at diaDexus, to its board of directors, today.
Lindsay has held key leadership roles at Millenium Pharmaceuticals and Regeneron Pharmaceuticals. He currently heads a biopharmaceutical-consulting firm, Milestone Consulting and is a non-executive director at Sequenom and ArQule.
Sebastian Meyer-Plath returned to Bruker Daltonics as vice president for its nuclear, biological, and chemical business and as a managing director of Bruker Daltonik GmbH, the Bruker Daltonik operation in Leipzig, Germany, the company said yesterday.
He originally joined Bruker in 1993, and held several project and product management positions in the company. He left in 2002 for Germany's Advalytix AG and joined Smiths Detection as vice president of sales & marketing in 2003.
Spotfire appointed Christian Marcazzo as senior director of life sciences marketing, the company said yesterday.
Prior to joining Spotfire, Marcazzo served as vice president of business development at InforSense.
At its Oct. 25 meeting, University of Oklahoma's Board of Regents decided to bring Jizhong Zhou to the university as a functional genomics researcher, said Lee Williams, vice president of research. Zhou's genomics laboratory on campus is expected to be fully operational by January 2006.
Prior to his OU appointment, Zhou was in Oak Ridge, Tenn. at Oak Ridge National Laboratory.
Lawrence R. Moreau has been elected to Sequenom's Board of Directors and will be the chairman of the Audit Committee, the company said this week.
Moreau, currently retired, founded financial advisory firm, Moreau and Company, and investment banking firm, Moreau Capital Corporation. He also was a board member and a licensed financial principal of an investment banking firm, vice-president of Pacific Enterprises (now Sempra Energy). From 2003 to 2005, Moreau served on InterMix Media's board of directors. He's on the board of Chatsworth Products at this time.
John Sharp, Sequenom's current vice-president of finance, has been appointed Sequenom's new treasurer and principal financial officer, the company said this week.
Sharp became vice-president in November 2004, when he left the director position at Diversa Corporation, which he held from August 2000. Sharp was a senior audit manager at PricewaterhouseCoopers from 1994 to 2000.
Clinical Data appointed Carol Reed as senior vice-president and chief medical officer this week.
Reed joins Clinical Data from Genaissance Pharmaceuticals (the merger closed Oct. 7), where she served as vice president of medical affairs since 2003. Prior to Genaissance, Reed was an associate medical director at Bayer Pharmaceuticals and an associate director at the Hospital of St. Raphael. She received a Master of Science. in molecular biology from the University of Illinois and a M.D. from Rush Medical College.
John A. Schultz is the new senior vice president of business development at Clinical Data.
Prior to this appointment, he was vice-president at Pathway Diagnostics. He headed the Life Sciences Business Development activities at UCLA's Office of Intellectual Property Administration and was director at Specialty Laboratories. Schultz was general manager for the ImmunoSystems' BioChem Pharma (now Shire Pharmaceuticals) and held positions at Sigma-Aldrich, Isolab (now PerkinElmer), and Mallinckrodt's Forma Scientific (now Thermo Electron). He received a Bachelor of Science from Washington State University and a Master of Business Administration from the Garvin School of International Management.